 Abstract | | |
CONTEXT: The formation of red cell alloantibodies resulting from both transfusion and pregnancy can cause adverse effects from allogeneic blood transfusions. Alloanti-E is commonly detected among Thai and Asian populations.
AIMS: This study aimed to determine RHCE*E and RHCE*e genotype incompatibility in a southern Thai Muslim population and to compare it with those previously reported for other populations.
SUBJECTS AND METHODS: Nine hundred and twenty-seven DNA samples obtained from 427 unrelated healthy blood donors from southern Thai Muslims and 500 samples from Central Thais were included. Samples were genotyped for RHCE*E and RHCE*e using an in-house polymerase chain reaction with the sequence-specific primer technique.
RESULTS: Significant differences were found when we compared the allele frequencies of the RHCE*E and RHCE*e between southern Thai Muslims and Central Thais: RHCE*E 0.162 versus 0.197 and RHCE*e 0.838 versus 0.803 and also found in Chinese, American native, Japanese, Korean, Alaskan native, Hawaiian, South Asian, Brazilian Japanese-descendant, and Malay Malaysian populations (P < 0.05). In addition, the E/e incompatibilities among southern Thai Muslims and Central Thais were 24.23% and 26.71%, respectively.
CONCLUSIONS: This study was the first to determine the RHCE*E and RHCE*e genotype incompatibility among southern Thai Muslims, enabling the estimation of their potential alloimmunization risk. These data could be useful to provide safe blood transfusions across ethnic populations.
Keywords: E/e incompatibility, RHCE*E and RHCE*e genotype, southern Thai Muslims
How to cite this article:
Tanwarawutthikul P, Intharanut K, Mitundee S, Nathalang O. RHCE*E and RHCE*e genotype incompatibility in a southern Thai Muslim population. Asian J Transfus Sci 2022;16:50-5 |
How to cite this URL:
Tanwarawutthikul P, Intharanut K, Mitundee S, Nathalang O. RHCE*E and RHCE*e genotype incompatibility in a southern Thai Muslim population. Asian J Transfus Sci [serial online] 2022 [cited 2022 Aug 8];16:50-5. Available from: https://www.ajts.org/text.asp?2022/16/1/50/345964 |
| Introduction | |  |
Red cell antibodies of a certain specificity are produced following the immunization of a corresponding antigen-negative individual through pregnancy or transfusion. Blood group antigen frequencies vary in different populations.[1],[2] Factors influencing red cell alloimmunization depend not only on the dose and immunogenicity of the antigen but also on different antigen distribution-related variables. In Thailand, anti-MNS7 (Mia) and anti-E are usually found among multitransfused patients.[3],[4],[5] In particular, anti-E is detected in a single antibody of those patients at about 13.19%, while found in combinations, such as anti-E plus -Mia, -c or -Jka, at about 30.24%.[3] Hence, the antigen typing of Rh (C, c, E, and e) and MNS7 is an essential requirement before the first transfusion among patients with thalassemia.[6] Moreover, the implementation of antigen typing to identify phenotype-matched donors could reduce alloimmunization or hemolytic transfusion reactions.[7],[8]
At present, red cell genotyping is more feasible than standard serological phenotyping for large-scale population screening determinations. The RHCE gene is located on chromosome 1p36.11 and encompasses 10 exons spanning over 58 kb of genomic DNA. The E and e antigens are associated with a biallelic polymorphism caused by a single-nucleotide variation, c.676C>G (rs609320) in exon 5 predicting Pro226 (E) and Ala226 (e) of the RhCE protein.[1],[2]
A comparative study of RHCE*E/*e alleles between Central and northern Thais revealed no significant difference.[9] In contrast, other alleles, for example, GYPB*S/*s, DI *A/*B, and JK*A/*B, among southern Thai Muslims significantly differed from Central and northern Thais.[10],[11],[12] Therefore, those data have helped achieve decreased risk for transfusions in three Thai populations. However, data regarding RHCE*E/*e alleles among southern Thai Muslims remain limited. This study thus aimed to determine RHCE*E and RHCE*e genotype incompatibility in a southern Thai Muslim population and compare it with those previously reported for other populations.
| Subjects and Methods | | |
Subjects and controls
Peripheral venous blood was collected in EDTA-anticoagulated blood from 927 unrelated healthy Thai blood donors. Five hundred samples included 300 samples from our previous study[9] and an additional 200 samples from the National Blood Centre, Thai Red Cross Society, Bangkok. In addition, 427 samples were acquired from the Regional Blood Centre 12th Songkhla, Thai Red Cross Society, Songkhla, Thailand. Informed consent was obtained from each subject. This study was approved by the Committee on Human Rights Related to Research Involving Human Subjects, Thammasat University, Pathum Thani, Thailand (COE No. 018/2562), and the Committee for Research in Human Subjects, National Blood Centre, Thai Red Cross Society (COA No. NBC 18/2019). Genomic DNA was extracted from peripheral blood samples using the Genomic DNA Extraction Kit (REAL Genomics, RBC Bioscience, Taipei, Taiwan) and then stored at −20°C until used for genotyping. Three identified samples of DNA consisting of 1 E + e−, 1 E + e+, and 1 E − e + phenotypes, confirmed by DNA sequencing, were used as controls.
RHCE*E and RHCE*e genotyping by polymerase chain reaction-sequence-specific primer
RHCE*E and RHCE*e alleles were detected using standard polymerase chain reaction-sequence-specific primer (PCR-SSP). The sequences of the primer combinations used in this study, the product sizes, and final concentrations (μM/L) are shown in [Table 1]. All primers were designed by NCBI software. In brief, 1 μL of genomic DNA (50 ng/μL) was amplified in 10 μL of total volume (1 μL of 5 μM RH-E forward primer and 1 μL of 5 μM RH-CE reverse primer) to detect the RHCE*E. To detect the RHCE*e allele, 1 μL of 5 μM RH-e forward primer and 1 μL of 5 μM RH-CE reverse primer were used. The human growth hormone (HGH) gene was co-amplified with 1 μL of 6 μM HGH forward primer and 1 μL of 6 μM HGH reverse primer and used as an internal control. A standard PCR technique was used with a reaction mixture of 5 μL of 2X PCR (OnePCR Plus, GeneDirex, Taiwan) using a T100 Thermal Cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA). | Table 1: Sequences and final concentration of the primers for RHCE*E, RHCE*e, and human growth hormone
Click here to view |
The PCR technique consisted of one cycle of 95°C for 5 min, followed by 30 cycles at 95°C for 30 s, 62°C for 40 s, and 72°C for 30 s. The final step was a 5-min extension at 72°C, followed by storage at 4°C. After being amplified, the newly created products were electrophoresed at 100 volts with a 1.5% agarose gel using a 1X Tris-borate-EDTA buffer containing a 10,000X fluorescent DNA gel stain (SYBR Safe DNA gel stain, Invitrogen, Paisley, UK) and visualized using blue-light illumination. The product size of the PCR samples for both RHCE*E and RHCE*e alleles was 202 bp, whereas that of the HGH gene internal control was 434 bp.
DNA sequencing
The results of the PCR-SSP were confirmed by sequencing the genomic DNA of 30 genotyped donors (10 RHCE*E/RHCE*E, 10 RHCE*E/RHCE*e, and 10 RHCE*e/RHCE*e). A 560 bp fragment that contained single nucleotide polymorphisms (SNPs) (c. 676C/G) was obtained from PCR amplification. The PCR conditions of the DNA sequencing were similar to those for the RHCE*E and RHCE*e genotyping. The sequences of primer pairs of the gene target are shown in [Table 1]. For each PCR reaction, 2 μl of genomic DNA (50 ng/μL) was amplified in a total volume of 50 μL, using 3 μl of 10 μM SE-RHCE forward primers, and 3 μl of 10 μM SE-RHCE reverse primer for each reaction. The PCR was performed with 25 μL of a 2X PCR reaction mixture (Phusion High-Fidelity PCR Master Mix; New England BioLabs, Ipswich, MA, USA) and 17 μL of sterile distilled water in a T100 Thermal cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Subsequently, the PCR products were purified using a gel extraction kit (GeneJET gel extraction kit, Thermo Fisher Scientific, MA, USA), and eluted fragments were then sequenced (First Base Laboratories Sdn Bhd, Selangor, Malaysia) using those PCR primers.
Statistical analysis
Gene and allele frequencies were simply estimated by counting the number of times each gene and allele was observed in samples from southern Thai Muslims and Central Thais. The Chi-square (χ2) test was used to test for the Hardy–Weinberg equilibrium for the RHCE (E/e) gene. A Pearson's Chi-squared test was conducted between the independent variables of RHCE*E and RHCE*e allele frequencies among southern Thai Muslims and the independent variables of previously reported populations,[9],[13],[14],[15],[16] using the allele frequencies in a 2 × 2 contingency table to determine whether the allele frequencies of southern Thai Muslims differed significantly from those of other populations. All statistical analyses were conducted using SPSS, Version 16.0 (SPSS Inc., Chicago, IL, USA). P < 0.05 was established as statistically significant.
In addition, the percentage of predicted E/e incompatibilities was calculated by (*E/*E [*e/*e+*E/*e] + *e/*e [*E/*E+*E/*e]); *E/*E, *E/*e and * e/*e were the percentage of genotype frequencies in each population. The estimated risk of E/e alloimmunization was obtained by multiplying the probability of being predicted by the E/e-negative phenotype frequency by the probability of having a predicted E/e phenotype frequency,[10],[17] i.e., anti-E or anti-e by considering the E/e pair of antigens in four conditions:
- E/e donor to e/e patient (risk of anti-E production): E/e x e/e
- E/E donor to e/e patient (risk of anti-E production): E/E x e/e
- e/e donor to E/E patient (risk of anti-e production): E/e x E/E
- E/e donor to E/E patient (risk of anti-e production): E/e x E/E.
Overall, the global risk of alloimmunization related to RhE/e incompatibilities is the sum of those calculations in four conditions.
| Results | | |
The results of a PCR-SSP were used to differentiate between the RHCE*E and RHCE*e alleles. The first and second mixes could identify the RHCE*E and RHCE*e alleles with an amplified product size of 202 bp, as shown in [Figure 1]. The validated genotyping results of 3 DNA controls were consistent with each other, and 30 DNA samples tested by PCR-SSP showed a 100% concordance with the DNA sequencing results [Figure 2]. | Figure 1: Results of RHCE*E and RHCE*E genotyping by polymerase chain reaction-sequence-specific primer. Lane M: 100 bp DNA molecular weight marker (Fermentas, Carlsbad, CA, USA). The 434 bp amplification product of the HGH control primer is presented in all lanes, indicating successful polymerase chain reaction amplification. The RHCE*E and RHCE*E genotype was deduced from the presence of amplification product specific for RHCE*E and RHCE*E (202 bp). Lanes 1E and 1e = RHCE*E/RHCE*E, Lanes 2E and 2e and 4E and 4e = RHCE*E/RHCE*E, Lanes 3E and 3e, 5E and 5e and 6E and 6e = RHCE*E/RHCE*E, and 7E and 7e = no template control, respectively
Click here to view |
 | Figure 2: Electropherograms of the RHCE gene at the RHCE*E and RHCE*e polymorphism region, single-nucleotide variation c.676C>G (rs609320). (a) Homozygous state of the c.676C identified in the E+e−phenotype, (b) heterozygous state of the c.676C/G identified in the E+e+phenotype, and (c) homozygous state of the c.676G identified in the E−e+phenotype
Click here to view |
A total of 427 DNA samples from southern Thai Muslims and 500 samples from Central Thais were examined for the RHCE*E and RHCE*e alleles using the standard PCR-SSP technique. The RHCE*E and RHCE*e genotype and allele frequencies in southern Thai Muslims and Central Thais are shown in [Table 2]. The genotypes of the 427 southern Thai Muslims and 500 Central Thais were consistent with each other according to the Hardy–Weinberg equilibrium (χ2 = 4.751, DF = 2, P = 0.093, and χ2 = 0.056, DF = 2, P = 0.962, respectively). Moreover, RHCE*e/RHCE*e was the most common genotype (71.89% and 64.60%), followed by RHCE*E/RHCE*e (23.89% and 31.40%) and RHCE*E/RHCE*E (4.22% and 4.00%). | Table 2: RHCE*E and RHCE*e genotype and allele frequencies among southern Thai Muslims and Central Thais
Click here to view |
The RHCE*E and RHCE*e genotype and allele frequencies in southern Thai Muslims and other populations[9],[13],[14],[15],[16] are shown in [Table 3]. Significant differences were found when we compared the RHCE*E and RHCE*e allele frequencies among southern Thai Muslims and Central Thais: RHCE*E 0.162 versus 0.197 and RHCE*e 0.838 versus 0.803. Furthermore, the allele frequencies among southern Thai Muslims also displayed significant differences with Chinese, American native, Japanese, Korean, Alaskan native/Aleut, Hawaiian/Pacific Islander, South Asian, Brazilian Japanese-descendant, and Malay Malaysian populations (P < 0.05). | Table 3: Comparison of allele and genotype frequencies, prediction of E/e incompatibilities, and alloimmunization risk from different ethnic populations
Click here to view |
For the next step, E/e incompatibilities were predicted in different populations [Table 3]. The E/e incompatibilities among southern Thai Muslims and Central Thais were 24.23% and 26.71%, respectively. To sort from low to high, the South Asian population had the lowest percentage of prediction of E/e incompatibilities, followed by the Italian (Naples), Filipino, northern Thai, southern Thai Muslim, Southeast Asian, Central Thai, Hawaiian/Pacific Islander, Chinese, Brazilian Japanese-descendant, American native, Japanese, Alaskan native/Aleut, Malay Malaysian, and Korean populations. In addition, the risk of E and e alloimmunization among populations was analyzed, as shown in [Table 3]. An important finding of our study is that, according to the genotype data, the proportion of estimated risk of E alloimmunization was more than 1.24-fold higher in the Korean population (0.2498) than in southern Thai Muslims (0.2021).
| Discussion | | |
In general, the Rh blood group antigens are highly immunogenic; hence, the prevalence of anti-E is often detected in multiparous women and in patients with repeated red cell transfusions among Asian populations. They may require antigen-negative donor's red cells for transfusions. The accessibility of appropriate transfusions depends on the compatibility of a patient's ancestral genetic background and the ancestry of the majority of blood donors in the population.[18] Southern Thai Muslims usually share strong ethnic, linguistic, religious, and cultural bonds with the people across the Thai-Malaysian border, resulting in higher genetic similarities with Malaysians than with people in other regions of Thailand.[19] For RHCE*E and RHCE*e allele frequencies in northern and Central Thais, no significant difference was observed.[9]
In this study, we developed the PCR-SSP to determine those two alleles, and the validated PCR-SSP genotyping results agreed with the DNA sequencing results; hence, the genotyping results were accurate and reliable. The RHCE*E and RHCE*e allele frequencies among southern Thai Muslims were described and compared with other populations. For three Thai populations, the RHCE*E allele among southern Thai Muslims was significantly lower than that of Central Thais, but no significant difference was found compared with northern Thais.[9] In addition, we observed marked differences across other Asian populations.[13],[16] The differences and similarities of the two alleles could lead to predicting E/e incompatibilities and the risk of E and e alloimmunization. Concerning the South Asian population, our data displayed the lowest estimated E/e incompatibilities and risk of E alloimmunization. Those estimated results, however, were not perfectly correlated with the actual alloanti-E that can be frequently observed in Indian populations.[20],[21] This discrepant data may have occurred because the South Asian population was not specified as only Indian and the samples were from volunteer blood donors residing in the USA,[13] who perhaps do not truly represent a South Asian population. On the contrary, correlated data between the highest predictable and actual E alloimmunization found in a Korean population were demonstrated.[22]
Knowing the prevalence of red cell polymorphisms in different populations and ethnicities is useful in transfusion medicine because red cell antigen incompatibilities are responsible for alloantibody formation. In Thailand, our findings support the dissimilar data of blood group polymorphisms among Thai populations in related studies.[9],[10],[11],[12] Therefore, RhE/e incompatibilities constituted the focused attention on the wide variability in transfusions across the ethnic groups of Thailand. In addition, the implementation of RhE/e genotyping by PCR-SSP is valuable for transfusion-dependent patients due to the following advantages. First, the results can be obtained within 2 h; second, the cost would be cheaper than the imported kit; and third, its simplicity and reproducibility is appropriate for routine testing. To achieve the appropriate antigen-matched donors, expanding the nationwide database from this study and ensuring database accuracy will reduce adverse transfusion reactions.
| Conclusions | | |
This study was the first to determine RHCE*E and RHCE*e genotype incompatibility among southern Thai Muslims, enabling the estimation of their potential alloimmunization risk. These data could be useful to better provide safe blood transfusions across ethnic populations.
Financial support and sponsorship
This study was financially supported by the Thammasat University Research Fund.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Reid ME, Lomas-Francis C, Olsson M. The Blood Group Antigen Factsbook. 3 rd ed. New York: Academic Press; 2012.  |
| 2. | Daniels G. Human Blood Groups. 3 rd ed. Malden, MA: Blackwell Science; 2013. |
| 3. | Kupatawintu P, Emthip M, Sungnoon D, O-vataga P, Manakul. V, Limtamaporn S, et al. Unexpected antibodies of patients, blood samples sent for testing at NBC. TRCS. (in Thai) J Hematol Trans Med 2010;20:255-62. |
| 4. | Po-ngernnak P, Sasjeenpong S, Chuesakul K, Pangwangthong K. The prevalence of red blood cell alloantibodies in lower Northern Thailand. J Med Assoc Thai 2016;99:1337-43. |
| 5. | Promwong C, Siammai S, Hassarin S, Buakaew J, Yeela T, Soisangwan P, et al. Frequencies and specificities of red cell alloantibodies in the Southern Thai population. Asian J Transfus Sci 2013;7:16-20. [ PUBMED] [Full text] |
| 6. | Fucharoen S, Tanphaichitr VS, Torcharus K, Viprakasit V, Mekaewkunchorn A. Clinical Practice Guidelines for Diagnosis and Management of Thalassemia Syndromes. (in Thai), Bangkok: P.A. Living; 2014. |
| 7. | Fung MK, Grossman BJ, Hillyer CD, Westhoff CM. Technical Manual. 18 th ed. Bethesda: AABB; 2014. |
| 8. | Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58-71. |
| 9. | Intharanut K, Bejrachandra S, Nathalang S, Leetrakool N, Nathalang O. Red cell genotyping by multiplex pcr identifies antigen-matched blood units for transfusion-dependent Thai patients. Transfus Med Hemother 2017;44:358-64. |
| 10. | Nathalang O, Ang RM, Kurin B, Limprasert S, Mitundee S, Leetrakool N, et al. Predicted S and s phenotypes from genotyping results among Thai populations to prevent transfusion-induced alloimmunization risks. Transfus Apher Sci 2018;57:582-6. |
| 11. | Chesor M, Mitundee S, Nathalang S, Thattanon P, Intharanut K, Tobunluepop P, et al. DI*A and DI*B allele frequencies among Southern Thai blood donors. Indian J Hematol Blood Transfus 2018;34:506-9. |
| 12. | Puobon U, Intharanut K, Mitundee S, Nathalang O. Determining of JK*A and JK*B allele frequency distribution among Muslim blood donors from Southern Thailand. Malays J Med Sci 2019;26:58-65. |
| 13. | Delaney M, Harris S, Haile A, Johnsen J, Teramura G, Nelson K. Red blood cell antigen genotype analysis for 9087 Asian, Asian American, and native American blood donors. Transfusion 2015;55:2369-75. |
| 14. | Belsito A, Costa D, Fiorito C, De Iorio G, Casamassimi A, Perrotta S, et al. Erythrocyte genotyping for transfusion-dependent patients at the Azienda Universitaria Policlinico of Naples. Transfus Apher Sci 2015;52:72-7. |
| 15. | Flôres MA, Visentainer JE, Guelsin GA, Fracasso Ade S, de Melo FC, Hashimoto MN, et al. Rh, Kell, Duffy, Kidd and Diego blood group system polymorphism in Brazilian Japanese descendants. Transfus Apher Sci 2014;50:123-8. |
| 16. | Musa RH, Muhamad NA, Hassan A, Ayob Y, Yusoff NM. Molecular basis of Rh blood group system in the Malaysian population. Asian J Transfus Sci 2015;9:48-54. [ PUBMED] [Full text] |
| 17. | del Peón-Hidalgo L, Pacheco-Cano MG, Zavala-Ruiz M, Madueño-López A, García-González A. Blood group frequencies and ABO and RhD incompatibilities in La Paz, Baja California Sur, Mexico. Salud Publica Mex 2002;44:406-12. |
| 18. | Khan J, Delaney M. Transfusion support of minority patients: extended antigen donor typing and recruitment of minority blood donors. Transfus Med Hemother 2018;45:271-6. |
| 19. | Montesano MJ, Jory P. Thai South and Malay North: Ethnic Interactions on a Plural Peninsula. 1 st ed. Singapore: NUS Press; 2008. |
| 20. | Makroo RN, Bhatia A, Hegde V, Chowdhry M, Thakur UK, Rosamma NL. Antibody screening identification in the general patient population at a tertiary care hospital in New Delhi, India. Indian J Med Res 2014;140:401-5. [ PUBMED] [Full text] |
| 21. | Gupta KP, Gajjar MD, Patel TR, Bhatnagar NM, Chaudhari N, Shah MC. Antibody screening and identification in donors and general patients at a tertiary care teaching hospital in Western India. Asian J Transfus Sci 2019;13:34-8. [ PUBMED] [Full text] |
| 22. | Shin JW. Unexpected red cell antibody detection by conditional combination of LISS/Coombs and NaCl/Enzyme gel tests at a tertiary care hospital in Korea: A 5-year study. Blood Res 2013;48:217-21. |
Correspondence Address:
Oytip Nathalang
Graduate Program in Medical Technology, Faculty of Allied Health Sciences, Thammasat University, 99 Moo 18 Klongluang, Pathum Thani 12120
Thailand
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ajts.AJTS_10_20
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3] |
